Mirati Therapeutics (NASDAQ:MRTX) Now Covered by Analysts at StockNews.com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Stock analysts at StockNews.com began coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Get Free Report) in a report released on Monday. The firm set a “sell” rating on the biotechnology company’s stock. MRTX has been the topic of a number of other reports. Stifel Nicolaus reaffirmed a “hold” rating and issued a $59.00 price […]
Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 845,566 shares were traded during trading, a decline of 36% from the previous session’s volume of 1,312,155 shares.The stock last traded at $58.69 and had previously closed at $58.80. Wall Street Analysts Forecast Growth A number of analysts […]
Mirati Therapeutics (NASDAQ:MRTX) Sees Strong Trading Volume themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research note published on Sunday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Several other analysts also recently weighed in on MRTX. Leerink Partnrs downgraded Mirati Therapeutics from an outperform rating to a market perform rating in […]